Advertisement

More articles from Biology of Human Tumors

  • mGPDH is a metformin target in thyroid cancer
    Shilpa Thakur, Brianna Daley, Kelli Gaskins, Vasyl V Vasko, Myriem Boufraqech, Dhaval Patel, Carole Sourbier, Jeff M Reece, Sheue-yann Cheng, Electron Kebebew, Sunita K Agarwal, Joanna Klubo-Gwiezdzinska
    Clinical Cancer Research Jan 2018, clincanres.3167.2017; DOI: 10.1158/1078-0432.CCR-17-3167
  • CSC-Mø facilitates the progression and ADT resistance of PCa
    Hai Huang, Chao Wang, Fei Liu, Hui-zhen Li, Guang Peng, Xu Gao, Ke-qin Dong, Hong-ru Wang, De-pei Kong, Min Qu, Li-he Dai, Kai-jian Wang, Zhe Zhou, Jun Yang, Ze-yu Yang, Yan-qiong Cheng, Qin-qin Tian, Dan Liu, Chuan-liang Xu, Dan-feng Xu, Xin-gang Cui, Ying-hao Sun
    Clinical Cancer Research Jan 2018, clincanres.0461.2018; DOI: 10.1158/1078-0432.CCR-18-0461
  • Telatinib for Pseudomyogenic Hemangioendothelioma
    David G.P. van IJzendoorn, Stefan Sleijfer, Hans Gelderblom, Ferry A.L.M. Eskens, Geert J.L.H. van Leenders, Karoly Szuhai, Judith V.M.G. Bovée
    Clinical Cancer Research Mar 2018, DOI: 10.1158/1078-0432.CCR-17-3512
  • Combination Approach for Liquid Biopsies
    Joanna Przybyl, Jacob J. Chabon, Lien Spans, Kristen N. Ganjoo, Sujay Vennam, Aaron M. Newman, Erna Forgó, Sushama Varma, Shirley Zhu, Maria Debiec-Rychter, Ash A. Alizadeh, Maximilian Diehn, Matt van de Rijn
    Clinical Cancer Research Feb 2018, DOI: 10.1158/1078-0432.CCR-17-3704
  • Endocrine-Resistant Breast Cancer Sensitivity to TRAIL
    Luke Piggott, Andreia Silva, Timothy Robinson, Angelica Santiago-Gómez, Bruno M. Simões, Michael Becker, Iduna Fichtner, Ladislav Andera, Philippa Young, Christine Morris, Peter Barrett-Lee, Fouad Alchami, Marco Piva, Maria dM. Vivanco, Robert B. Clarke, Julia Gee, Richard Clarkson
    Clinical Cancer Research Jan 2018, DOI: 10.1158/1078-0432.CCR-17-1381
  • Polyclonal Lymph Node Metastasis
    Peter J. Ulintz, Joel K. Greenson, Rong Wu, Eric R. Fearon, Karin M. Hardiman
    Clinical Cancer Research Dec 2017, DOI: 10.1158/1078-0432.CCR-17-1425
  • Tumor features associated to immune-phenotypes
    David Tamborero, Carlota Rubio-Perez, Ferran Muiños, Radhakrishnan Sabarinathan, Josep Maria Piulats, Aura Muntasell, Rodrigo Dienstmann, Nuria Lopez-Bigas, Abel Gonzalez-Perez
    Clinical Cancer Research Jan 2018, clincanres.3509.2017; DOI: 10.1158/1078-0432.CCR-17-3509
  • Immunophenotypic and molecular classification of PDAC
    Martin Wartenberg, Silvia Cibin, Inti Zlobec, Erik Vassella, Serenella M.M. Eppenberger-Castori, Luigi Terracciano, Micha Eichmann, Mathias Worni, Beat Gloor, Aurel Perren, Eva Karamitopoulou
    Clinical Cancer Research Jan 2018, clincanres.3401.2017; DOI: 10.1158/1078-0432.CCR-17-3401
  • ISGs in tamoxifen-resistant and radioresistant breast cancer
    Annemarie E.M. Post, Marcel Smid, Anika Nagelkerke, John W.M. Martens, Johan Bussink, Fred CJG Sweep, Paul N Span
    Clinical Cancer Research Jan 2018, clincanres.2551.2017; DOI: 10.1158/1078-0432.CCR-17-2551
  • Multiple myeloma cross-presents PR1
    Gheath Alatrash, Alexander A Perakis, Celine Kerros, Haley L Peters, Pariya Sukhumalchandra, Mao Zhang, Haroon Jakher, Madhushree Zope, Rebecca S. Patenia, Anna Sergeeva, Shuhua Yi, Ken H. Young, Anne V Philips, Amanda C Herrmann, Haven R Garber, Na Qiao, Jinsheng Weng, Lisa S. St. John, Sijie Lu, Karen Clise-Dwyer, Elizabeth A. Mittendorf, Qing Ma, Jeffrey J. Molldrem
    Clinical Cancer Research Jan 2018, clincanres.2626.2017; DOI: 10.1158/1078-0432.CCR-17-2626

Pages